Researchers at the University of Oxford have revealed which groups of people are at greatest risk of severe COVID-19 (leading to hospitalisation or death) from 14 days after their second vaccine dose, when substantial immunity should be expected.
New research from the University of Oxford has shown that the technology behind the Oxford-AstraZeneca COVID-19 vaccine has the potential to be used in treating cancer.
People who have received two doses of a COVID-19 vaccine are half as likely to get Long Covid if they go on to become infected with the virus, researchers at King’s College London have found.